Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) Voir le document au format PDF
Table des matières
Afficher le documentAuthors
Afficher le documentCountry Research Team Leaders
Afficher le documentLaboratory Support
Afficher le documentAcknowledgements
Afficher le documentAcronyms
Afficher le documentExecutive summary
Afficher le document1. Background
Ouvrir ce répertoire et afficher son contenu2. Methodology
Afficher le document3. Results
Ouvrir ce répertoire et afficher son contenu4. Discussion
Ouvrir ce répertoire et afficher son contenu5. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuTables
Ouvrir ce répertoire et afficher son contenuAnnexes
Afficher le documentOther documents in the EDM Research Series
Afficher le documentEDM Research Series No. 30
 

References

1. Matteelli A. et al. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine/pyrimethamine, Zanzibar, United Republic of Tanzania. Geneva, World Health Organization, 1990. (WHO/MAL/90.1055).

2. Walker GJA, Hogerzeil HV. Potency of ergometrine in tropical countries. Letter to the Editor. Lancet, 1988, ii: 393.

3. Hogerzeil HV, Walker GJA. Instability of (methyl) ergometrine in tropical climates: an overview. European Journal of Obstetrics Gynecology and Reproductive Biology, 1996, 69: 25-29.

4. Hogerzeil HV et al. Stability of essential drugs during shipment to the tropics. Letter to the Editor. British Medical Journal, 1992, 304: 210-212.

5. Nazerali H, Hogerzeil HV. The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study. British Medical Journal, 1998, 317: 512-513.

6. Wondemagegnehu E. Counterfeit and substandard drugs in Myanmar and Viet Nam. Geneva, World Health Organization; 1999. (WHO/EDM/QSM/99.3).

7. World Health Organization. Guidelines for the development of measures to combat counterfeit drugs, DMP-DAP Joint Project on Counterfeit Drugs. Geneva, World Health Organization, 1999. (WHO/EDM/QSM/99.1).

8. World Health Organization. Monitoring antimalarial drug resistance. Geneva, World Health Organization, 2002. (WHO/CDS/CSR/EPH/2002.17 and WHO/CDS/RBM/2002.39).

 

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018